Skip to main content
Erschienen in:

01.11.2007 | Original Contributions

DNA Ploidy Status and Prognosis in Colorectal Cancer: A Meta-Analysis of Published Data

verfasst von: Sergio E. A. Araujo, M.D., Wanderley M. Bernardo, M.D., Angelita Habr-Gama, M.D., Desiderio R. Kiss, M.D., Ivan Cecconello, M.D.

Erschienen in: Diseases of the Colon & Rectum | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In colorectal cancer, the negative effect of aneuploidy has been a controversy for more than 20 years. Studies to determine a survival-deoxyribonucleic acid content relationship have conflicting results. A systematic literature search followed by a meta-analysis of published studies addressing prognostic effect of aneuploidy for patients who underwent surgical treatment of colon and rectal cancer was conducted.

Methods

The main outcome measure was the five-year overall mortality rate after surgical resection. For the selected studies, we estimated this outcome for three subsets of patients through separate meta-analyses: 1) for all patients with colorectal cancer; 2) only between patients with Stage II colon cancer; and 3) only for studies in which follow-up losses were declared. The presence of publication bias was assessed with a funnel plot for asymmetry.

Results

A total of 5,478 patients with colorectal cancer were represented in 32 studies (Group 1), we estimated a reduction in the five-year overall mortality from 43.2 percent for aneuploid tumors to 29.2 percent for diploid tumors (combined relative risk--.44; 95 percent confidence interval--.34-.55; P-lt;-.001). In addition, 357 patients with Stage II colon cancer (Group 2) extracted from three studies had an absolute reduction of 14.3 percent in five-year overall mortality favoring diploid tumors (combined relative risk--.93; 95 percent confidence interval--.29-.89; P--.001). Lastly, of 14 studies in which follow-up losses were declared (Group 3), 2,221 patients were represented and a 15.7 percent mortality reduction was measured favoring patients with diploid tumors (combined relative risk--.44; 95 percent confidence interval--.3-.61; P-lt;-.001).

Conclusions

Patients who undergo an aneuploid colorectal cancer surgical resection have a higher risk of death after five years. This finding may ultimately impact survival of patients with node-negative colon cancer through adjuvant therapy.
Literatur
1.
Zurück zum Zitat Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18–29.PubMedCrossRef Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18–29.PubMedCrossRef
2.
Zurück zum Zitat Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8–29PubMedCrossRef Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8–29PubMedCrossRef
3.
Zurück zum Zitat Friedlander ML, Hedley DW, Taylor IW. Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol 1984;37:961-4.PubMedCrossRef Friedlander ML, Hedley DW, Taylor IW. Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol 1984;37:961-4.PubMedCrossRef
4.
Zurück zum Zitat Barlogie B, Raber MN, Schumann J, et al. Flow cytometry in clinical cancer research. Cancer Res 1983;43:3982-7.PubMed Barlogie B, Raber MN, Schumann J, et al. Flow cytometry in clinical cancer research. Cancer Res 1983;43:3982-7.PubMed
5.
Zurück zum Zitat Wolley RC, Schreiber K, Koss LG, Karas M, Sherman A. DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Natl Cancer Inst 1982;69:15–22.PubMed Wolley RC, Schreiber K, Koss LG, Karas M, Sherman A. DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Natl Cancer Inst 1982;69:15–22.PubMed
6.
Zurück zum Zitat Quirke P, Fozard JB, Dixon MF, Dyson JE, Giles GR, Bird CC. DNA aneuploidy in colorectal adenomas. Br J Cancer 1986;53:477-1.PubMed Quirke P, Fozard JB, Dixon MF, Dyson JE, Giles GR, Bird CC. DNA aneuploidy in colorectal adenomas. Br J Cancer 1986;53:477-1.PubMed
7.
Zurück zum Zitat Goh HS, Jass JR. DNA content and the adenoma-carcinoma sequence in the colorectum. J Clin Pathol 1986;39:387-2.PubMedCrossRef Goh HS, Jass JR. DNA content and the adenoma-carcinoma sequence in the colorectum. J Clin Pathol 1986;39:387-2.PubMedCrossRef
8.
Zurück zum Zitat Scott NA, Rainwater LM, Wieand HS, et al. The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma. Dis Colon Rectum 1987;30:513-0.PubMedCrossRef Scott NA, Rainwater LM, Wieand HS, et al. The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma. Dis Colon Rectum 1987;30:513-0.PubMedCrossRef
9.
Zurück zum Zitat Fisher ER, Siderits RH, Sass R, Fisher B. Value of assessment of ploidy in rectal cancers. Arch Pathol Lab Med 1989;113:525-.PubMed Fisher ER, Siderits RH, Sass R, Fisher B. Value of assessment of ploidy in rectal cancers. Arch Pathol Lab Med 1989;113:525-.PubMed
10.
Zurück zum Zitat Jass JR, Mukawa K, Goh HS, Love SB, Capellaro D. Clinical importance of DNA content in rectal cancer measured by flow cytometry. J Clin Pathol 1989;42:254-.PubMedCrossRef Jass JR, Mukawa K, Goh HS, Love SB, Capellaro D. Clinical importance of DNA content in rectal cancer measured by flow cytometry. J Clin Pathol 1989;42:254-.PubMedCrossRef
11.
Zurück zum Zitat Kokal WA, Gardine RL, Sheibani K, et al. Tumor DNA content in resectable, primary colorectal carcinoma. Ann Surg 1989;209:188-3.PubMedCrossRef Kokal WA, Gardine RL, Sheibani K, et al. Tumor DNA content in resectable, primary colorectal carcinoma. Ann Surg 1989;209:188-3.PubMedCrossRef
12.
Zurück zum Zitat Heimann TM, Miller F, Martinelli G, et al. Significance of DNA content abnormalities in small rectal cancers. Am J Surg 1990;159:199–202.PubMedCrossRef Heimann TM, Miller F, Martinelli G, et al. Significance of DNA content abnormalities in small rectal cancers. Am J Surg 1990;159:199–202.PubMedCrossRef
13.
Zurück zum Zitat Halvorsen TB, Johannesen E. DNA ploidy, tumour site, and prognosis in colorectal cancer. A flow cytometric study of paraffin-embedded tissue. Scand J Gastroenterol 1990;25:141-.PubMedCrossRef Halvorsen TB, Johannesen E. DNA ploidy, tumour site, and prognosis in colorectal cancer. A flow cytometric study of paraffin-embedded tissue. Scand J Gastroenterol 1990;25:141-.PubMedCrossRef
14.
Zurück zum Zitat Enker WE, Kimmel M, Cibas ES, Cranor ML, Melamed MR. DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival. J Natl Cancer Inst 1991;83:701-.PubMedCrossRef Enker WE, Kimmel M, Cibas ES, Cranor ML, Melamed MR. DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival. J Natl Cancer Inst 1991;83:701-.PubMedCrossRef
15.
Zurück zum Zitat Giaretti W, Danova M, Geido E, et al. Flow cytometric DNA index in the prognosis of colorectal cancer. Cancer 1991;67:1921-.PubMedCrossRef Giaretti W, Danova M, Geido E, et al. Flow cytometric DNA index in the prognosis of colorectal cancer. Cancer 1991;67:1921-.PubMedCrossRef
16.
Zurück zum Zitat Harlow SP, Eriksen BL, Poggensee L, et al. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas. Cancer Res 1991;51:2403-.PubMed Harlow SP, Eriksen BL, Poggensee L, et al. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas. Cancer Res 1991;51:2403-.PubMed
17.
Zurück zum Zitat Witzig TE, Loprinzi CL, Gonchoroff NJ, et al. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer 1991;68:879-8.PubMedCrossRef Witzig TE, Loprinzi CL, Gonchoroff NJ, et al. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer 1991;68:879-8.PubMedCrossRef
18.
Zurück zum Zitat Michelassi F, Ewing C, Montag A, et al. Prognostic significance of ploidy determination in rectal cancer. Hepatogastroenterology 1992;39:222-.PubMed Michelassi F, Ewing C, Montag A, et al. Prognostic significance of ploidy determination in rectal cancer. Hepatogastroenterology 1992;39:222-.PubMed
19.
Zurück zum Zitat Li J, Jiang Y, Wei W, Zhang S. Clinical significance of cellular DNA ploidy in rectal cancer less than 3 cm in diameter. Chin Med Sci J 1993;8:143-.PubMed Li J, Jiang Y, Wei W, Zhang S. Clinical significance of cellular DNA ploidy in rectal cancer less than 3 cm in diameter. Chin Med Sci J 1993;8:143-.PubMed
20.
Zurück zum Zitat Yamazoe Y, Maetani S, Nishikawa T, Onodera H, Tobe T, Imamura M. The prognostic role of the DNA ploidy pattern in colorectal cancer analysis using paraffin-embedded tissue by an improved method. Surg Today 1994;24:30-.PubMedCrossRef Yamazoe Y, Maetani S, Nishikawa T, Onodera H, Tobe T, Imamura M. The prognostic role of the DNA ploidy pattern in colorectal cancer analysis using paraffin-embedded tissue by an improved method. Surg Today 1994;24:30-.PubMedCrossRef
21.
Zurück zum Zitat Chapman MA, Hardcastle JD, Armitage NC. Five-year prospective study of DNA tumor ploidy and colorectal cancer survival. Cancer 1995;76:383-.PubMedCrossRef Chapman MA, Hardcastle JD, Armitage NC. Five-year prospective study of DNA tumor ploidy and colorectal cancer survival. Cancer 1995;76:383-.PubMedCrossRef
22.
Zurück zum Zitat Nori D, Merimsky O, Samala E, et al. Tumor ploidy as a risk factor for disease recurrence and short survival in surgically-treated Dukes-B2 colon cancer patients. J Surg Oncol 1995;59:239-2.PubMedCrossRef Nori D, Merimsky O, Samala E, et al. Tumor ploidy as a risk factor for disease recurrence and short survival in surgically-treated Dukes-B2 colon cancer patients. J Surg Oncol 1995;59:239-2.PubMedCrossRef
23.
Zurück zum Zitat Kay EW, Mulcahy HE, Curran B, O’Donoghue DP, Leader M. An image analysis study of DNA content in early colorectal cancer. Eur J Cancer 1996;32A:612-.PubMedCrossRef Kay EW, Mulcahy HE, Curran B, O’Donoghue DP, Leader M. An image analysis study of DNA content in early colorectal cancer. Eur J Cancer 1996;32A:612-.PubMedCrossRef
24.
Zurück zum Zitat Takanishi DM Jr, Hart J, Covarelli P, Chappell R, Michelassi F. Ploidy as a prognostic feature in colonic adenocarcinoma. Arch Surg 1996;131:587-2.PubMed Takanishi DM Jr, Hart J, Covarelli P, Chappell R, Michelassi F. Ploidy as a prognostic feature in colonic adenocarcinoma. Arch Surg 1996;131:587-2.PubMed
25.
Zurück zum Zitat Tonouchi H, Matsumoto K, Kinoshita T, Itoh H, Suzuki H. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma: univariate and multivariate analysis. Dig Surg 1998;15:687-2.PubMedCrossRef Tonouchi H, Matsumoto K, Kinoshita T, Itoh H, Suzuki H. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma: univariate and multivariate analysis. Dig Surg 1998;15:687-2.PubMedCrossRef
26.
Zurück zum Zitat Yamamoto T, Matsumoto K, Iriyama K. Prognostic significance of the DNA index in a colorectal cancer. Surg Today 1998;28:792-.PubMedCrossRef Yamamoto T, Matsumoto K, Iriyama K. Prognostic significance of the DNA index in a colorectal cancer. Surg Today 1998;28:792-.PubMedCrossRef
27.
Zurück zum Zitat Lanza G, Gafa R, Santini A, et al. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Cancer 1998;82:49–59.PubMedCrossRef Lanza G, Gafa R, Santini A, et al. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Cancer 1998;82:49–59.PubMedCrossRef
28.
Zurück zum Zitat Flyger HL, Larsen JK, Nielsen HJ, Christensen IJ. DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival. Cytometry 1999;38:293–300.PubMedCrossRef Flyger HL, Larsen JK, Nielsen HJ, Christensen IJ. DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival. Cytometry 1999;38:293–300.PubMedCrossRef
29.
Zurück zum Zitat Risques RA, Moreno V, Marcuello E, et al. Redefining the significance of aneuploidy in the prognostic assessment of colorectal cancer. Lab Invest 2001;81:307-5.PubMed Risques RA, Moreno V, Marcuello E, et al. Redefining the significance of aneuploidy in the prognostic assessment of colorectal cancer. Lab Invest 2001;81:307-5.PubMed
30.
Zurück zum Zitat Geido E, Sciutto A, Rubagotti A, et al. Combined DNA flow cytometry and sorting with k-ras2 mutation spectrum analysis and the prognosis of human sporadic colorectal cancer. Cytometry 2002;50:216-4.PubMedCrossRef Geido E, Sciutto A, Rubagotti A, et al. Combined DNA flow cytometry and sorting with k-ras2 mutation spectrum analysis and the prognosis of human sporadic colorectal cancer. Cytometry 2002;50:216-4.PubMedCrossRef
31.
Zurück zum Zitat Russo A, Migliavacca M, Zanna I, et al. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up. Cancer Epidemiol Biomarkers Prev 2002;11:1322-1.PubMed Russo A, Migliavacca M, Zanna I, et al. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up. Cancer Epidemiol Biomarkers Prev 2002;11:1322-1.PubMed
32.
Zurück zum Zitat Berczi C, Bocsi J, Bartha I. Prognostic value of DNA ploidy status in patients with rectal cancer. Anticancer Res 2002;22:3737-1.PubMed Berczi C, Bocsi J, Bartha I. Prognostic value of DNA ploidy status in patients with rectal cancer. Anticancer Res 2002;22:3737-1.PubMed
33.
Zurück zum Zitat Garrity MM, Burgart LJ, Mahoney MR, et al. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes-B2 or C colon cancer: a North Central Cancer Treatment Group Study. J Clin Oncol 2004; 22:1572-2.PubMedCrossRef Garrity MM, Burgart LJ, Mahoney MR, et al. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes-B2 or C colon cancer: a North Central Cancer Treatment Group Study. J Clin Oncol 2004; 22:1572-2.PubMedCrossRef
34.
Zurück zum Zitat American Joint Commission on Cancer. AJCC Cancer staging manual. 6th ed. Springer, 2003. American Joint Commission on Cancer. AJCC Cancer staging manual. 6th ed. Springer, 2003.
35.
Zurück zum Zitat Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol 2004;22:3395-07.PubMedCrossRef Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol 2004;22:3395-07.PubMedCrossRef
36.
Zurück zum Zitat Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-4.PubMed Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-4.PubMed
37.
Zurück zum Zitat Melamed MR, Enker WE, Banner P, Janov AJ, Kessler G, Darzynkiewicz Z. Flow cytometry of colorectal carcinoma with three-year follow-up. Dis Colon Rectum 1986;29:184-.PubMedCrossRef Melamed MR, Enker WE, Banner P, Janov AJ, Kessler G, Darzynkiewicz Z. Flow cytometry of colorectal carcinoma with three-year follow-up. Dis Colon Rectum 1986;29:184-.PubMedCrossRef
38.
Zurück zum Zitat Enblad P, Glimelius B, Bengtsson A, Ponten J, Pahlman L. The prognostic significance of DNA content in carcinoma of the rectum and rectosigmoid. Acta Chir Scand 1987;153:453-.PubMed Enblad P, Glimelius B, Bengtsson A, Ponten J, Pahlman L. The prognostic significance of DNA content in carcinoma of the rectum and rectosigmoid. Acta Chir Scand 1987;153:453-.PubMed
39.
Zurück zum Zitat Schutte B, Reynders MM, Wiggers T, et al. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res 1987;47:5494-.PubMed Schutte B, Reynders MM, Wiggers T, et al. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res 1987;47:5494-.PubMed
40.
Zurück zum Zitat Rognum TO, Thorud E, Lund E. Survival of large bowel carcinoma patients with different DNA ploidy. Br J Cancer 1987;56:633-.PubMed Rognum TO, Thorud E, Lund E. Survival of large bowel carcinoma patients with different DNA ploidy. Br J Cancer 1987;56:633-.PubMed
41.
Zurück zum Zitat Givel JC, de Quay N, Albe X, Vassilakos P. Prognostic value of DNA ploidy of colorectal tumor cells [in French]. Helv Chir Acta 1989;55:679-3.PubMed Givel JC, de Quay N, Albe X, Vassilakos P. Prognostic value of DNA ploidy of colorectal tumor cells [in French]. Helv Chir Acta 1989;55:679-3.PubMed
42.
Zurück zum Zitat Heimann TM, Martinelli G, Szporn A, et al. Prognostic significance of DNA content abnormalities in young patients with colorectal cancer. Ann Surg 1989;210:792-.PubMedCrossRef Heimann TM, Martinelli G, Szporn A, et al. Prognostic significance of DNA content abnormalities in young patients with colorectal cancer. Ann Surg 1989;210:792-.PubMedCrossRef
43.
Zurück zum Zitat Albe X, Vassilakos P, Helfer-Guarnori K, et al. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry. Cancer 1990;66:1168-5.PubMedCrossRef Albe X, Vassilakos P, Helfer-Guarnori K, et al. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry. Cancer 1990;66:1168-5.PubMedCrossRef
44.
Zurück zum Zitat Robey-Cafferty SS, el-Naggar AK, Grignon DJ, Cleary KR, Ro JY. Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum. Mod Pathol 1990;3:261-.PubMed Robey-Cafferty SS, el-Naggar AK, Grignon DJ, Cleary KR, Ro JY. Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum. Mod Pathol 1990;3:261-.PubMed
45.
Zurück zum Zitat Schillaci A, Tirindelli DD, Ferri M, et al. Flow cytometric analysis in colorectal carcinoma: prognostic significance of cellular DNA content. Int J Colorectal Dis 1990;5:223-.PubMedCrossRef Schillaci A, Tirindelli DD, Ferri M, et al. Flow cytometric analysis in colorectal carcinoma: prognostic significance of cellular DNA content. Int J Colorectal Dis 1990;5:223-.PubMedCrossRef
46.
Zurück zum Zitat Baretton G, Gille J, Oevermann E, Lohrs U. Flow-cytometric analysis of the DNA-content in paraffin-embedded tissue from colorectal carcinomas and its prognostic significance. Virchows Arch B Cell Pathol Incl Mol Pathol 1991;60:123-1.PubMedCrossRef Baretton G, Gille J, Oevermann E, Lohrs U. Flow-cytometric analysis of the DNA-content in paraffin-embedded tissue from colorectal carcinomas and its prognostic significance. Virchows Arch B Cell Pathol Incl Mol Pathol 1991;60:123-1.PubMedCrossRef
47.
Zurück zum Zitat Bawani M, Tibrewala S, Copur S, Harris D, Gilman-Sachs A. DNA flow cytometry of colorectal carcinoma: correlation of DNA stemlines with other prognostic indices. Am J Gastroenterol 1991;86:191-.PubMed Bawani M, Tibrewala S, Copur S, Harris D, Gilman-Sachs A. DNA flow cytometry of colorectal carcinoma: correlation of DNA stemlines with other prognostic indices. Am J Gastroenterol 1991;86:191-.PubMed
48.
Zurück zum Zitat Bosari S, Lee AK, Wiley BD, Heatley GJ, Hamilton WM, Silverman ML. DNA quantitation by image analysis of paraffin-embedded colorectal adenocarcinomas and its prognostic value. Mod Pathol 1992;5:324-.PubMed Bosari S, Lee AK, Wiley BD, Heatley GJ, Hamilton WM, Silverman ML. DNA quantitation by image analysis of paraffin-embedded colorectal adenocarcinomas and its prognostic value. Mod Pathol 1992;5:324-.PubMed
49.
Zurück zum Zitat Koha M, Wikstrom B, Brismar B. Colorectal carcinoma. DNA ploidy pattern and prognosis with reference to tumor DNA heterogeneity. Anal Quant Cytol Histol 1992;14:367-2.PubMed Koha M, Wikstrom B, Brismar B. Colorectal carcinoma. DNA ploidy pattern and prognosis with reference to tumor DNA heterogeneity. Anal Quant Cytol Histol 1992;14:367-2.PubMed
50.
Zurück zum Zitat Silvestrini R, D’Agnano I, Faranda A, et al. Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience. Br J Cancer 1993;67:1042-.PubMed Silvestrini R, D’Agnano I, Faranda A, et al. Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience. Br J Cancer 1993;67:1042-.PubMed
51.
Zurück zum Zitat Bianchi A, Mallofre C, Serrano A, Sunol J, Barja J, Ubach M. DNA as a prognostic factor in colorectal cancer. A retrospective analysis of 34 patients [in Spanish]. Rev Esp Enferm Dig 1993;84:100-.PubMed Bianchi A, Mallofre C, Serrano A, Sunol J, Barja J, Ubach M. DNA as a prognostic factor in colorectal cancer. A retrospective analysis of 34 patients [in Spanish]. Rev Esp Enferm Dig 1993;84:100-.PubMed
52.
Zurück zum Zitat Foggi E, Carbognani P. The value of ploidy in the prognosis of the colorectal cancer. Acta Biomed Ateneo Parmense 1993;64:185-4.PubMed Foggi E, Carbognani P. The value of ploidy in the prognosis of the colorectal cancer. Acta Biomed Ateneo Parmense 1993;64:185-4.PubMed
53.
Zurück zum Zitat Mazzei T, Tonelli F, Mini E, et al. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma. Anticancer Res 1995;15:2247-3.PubMed Mazzei T, Tonelli F, Mini E, et al. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma. Anticancer Res 1995;15:2247-3.PubMed
54.
Zurück zum Zitat Zarbo RJ, Nakhleh RE, Brown RD, Kubus JJ, Ma CK, Mackowiak P. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Cancer 1997;79:2073-6.PubMedCrossRef Zarbo RJ, Nakhleh RE, Brown RD, Kubus JJ, Ma CK, Mackowiak P. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Cancer 1997;79:2073-6.PubMedCrossRef
55.
Zurück zum Zitat Cosimelli M, D’Agnano I, Tedesco M, et al. The role of multiploidy as unfavorable prognostic variable in colorectal cancer. Anticancer Res 1998;18:1957-5.PubMed Cosimelli M, D’Agnano I, Tedesco M, et al. The role of multiploidy as unfavorable prognostic variable in colorectal cancer. Anticancer Res 1998;18:1957-5.PubMed
56.
Zurück zum Zitat Sampedro A, Salas-Bustamante A, Lopez-Artimez M, Garcia-Muniz JL, Urdiales G. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma. Anal Quant Cytol Histol 1999;21:347-2.PubMed Sampedro A, Salas-Bustamante A, Lopez-Artimez M, Garcia-Muniz JL, Urdiales G. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma. Anal Quant Cytol Histol 1999;21:347-2.PubMed
57.
Zurück zum Zitat Michel P, Paresy M, Lepessot F, et al. Pre-operative kinetic parameter determination of colorectal adenocarcinomas. Prognostic significance. Eur J Gastroenterol Hepatol 2000;12:275-0.PubMedCrossRef Michel P, Paresy M, Lepessot F, et al. Pre-operative kinetic parameter determination of colorectal adenocarcinomas. Prognostic significance. Eur J Gastroenterol Hepatol 2000;12:275-0.PubMedCrossRef
58.
Zurück zum Zitat Araujo SE, Habr-Gama A, Sousa AH Jr, Venco FE, El-Ibrahim R. Valor prognóstico do conteúdo celular de DNA e da atividade proliferativa tumoral no câncer colorretal. Comparação com as variáveis clínico-patológicas convencionais. Rev bras Coloprocto 2000;20:178-0. Araujo SE, Habr-Gama A, Sousa AH Jr, Venco FE, El-Ibrahim R. Valor prognóstico do conteúdo celular de DNA e da atividade proliferativa tumoral no câncer colorretal. Comparação com as variáveis clínico-patológicas convencionais. Rev bras Coloprocto 2000;20:178-0.
59.
Zurück zum Zitat Buglioni S, D’Agnano I, Vasselli S, et al. p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy. Am J Clin Pathol 2001;116:360-.PubMedCrossRef Buglioni S, D’Agnano I, Vasselli S, et al. p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy. Am J Clin Pathol 2001;116:360-.PubMedCrossRef
60.
Zurück zum Zitat Karelia NH, Patel DD, Desai NS, et al. Prognostic significance of DNA aneuploidy and p21 ras oncoprotein expression in colorectal cancer and their role in the determination of treatment modalities. Int J Biol Markers 2001;16:97–104.PubMed Karelia NH, Patel DD, Desai NS, et al. Prognostic significance of DNA aneuploidy and p21 ras oncoprotein expression in colorectal cancer and their role in the determination of treatment modalities. Int J Biol Markers 2001;16:97–104.PubMed
61.
Zurück zum Zitat Lin JK, Chang SC, Yang SH, Jiang JK, Chen WC, Lin TC. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma. Hepatogastroenterology 2003;50:1927-2.PubMed Lin JK, Chang SC, Yang SH, Jiang JK, Chen WC, Lin TC. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma. Hepatogastroenterology 2003;50:1927-2.PubMed
62.
Zurück zum Zitat Grigolato P, Chioda C, Salerni B, et al. DNA index of colorectal carcinoma and follow-up [in Italian]. Pathologica 1992;84:311-.PubMed Grigolato P, Chioda C, Salerni B, et al. DNA index of colorectal carcinoma and follow-up [in Italian]. Pathologica 1992;84:311-.PubMed
63.
Zurück zum Zitat Sun XF, Carstensen JM, Stal O, et al. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma. Virchows Arch A Pathol Anat Histopathol 1993;423:443-.PubMedCrossRef Sun XF, Carstensen JM, Stal O, et al. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma. Virchows Arch A Pathol Anat Histopathol 1993;423:443-.PubMedCrossRef
64.
Zurück zum Zitat Deans GT, Williamson K, Hamilton P, et al. DNA densitometry of colorectal cancer. Gut 1993;34:1566-1.PubMedCrossRef Deans GT, Williamson K, Hamilton P, et al. DNA densitometry of colorectal cancer. Gut 1993;34:1566-1.PubMedCrossRef
65.
Zurück zum Zitat Deans GT, Williamson K, Heatley M, et al. The role of flow cytometry in carcinoma of the colon and rectum. Surg Gynecol Obstet 1993;177:377-2.PubMed Deans GT, Williamson K, Heatley M, et al. The role of flow cytometry in carcinoma of the colon and rectum. Surg Gynecol Obstet 1993;177:377-2.PubMed
66.
Zurück zum Zitat Sciallero S, Bonelli L, Geido E, et al. Lack of prognostic value of flow cytometric DNA content analysis in colorectal adenocarcinomas. Eur J Cancer 1994;30A:569.PubMedCrossRef Sciallero S, Bonelli L, Geido E, et al. Lack of prognostic value of flow cytometric DNA content analysis in colorectal adenocarcinomas. Eur J Cancer 1994;30A:569.PubMedCrossRef
67.
Zurück zum Zitat Tang R, Ho YS, You YT, et al. Prognostic evaluation of DNA flow cytometric and histopathologic parameters of colorectal cancer. Cancer 1995;76:1724-0.PubMedCrossRef Tang R, Ho YS, You YT, et al. Prognostic evaluation of DNA flow cytometric and histopathologic parameters of colorectal cancer. Cancer 1995;76:1724-0.PubMedCrossRef
68.
Zurück zum Zitat Pietra N, Sarli L, Sansebastiano G, Jotti GS, Peracchia A. Prognostic value of ploidy, cell proliferation kinetics, and conventional clinicopathologic criteria in patients with colorectal carcinoma: a prospective study. Dis Colon Rectum 1996;39:494–503.PubMedCrossRef Pietra N, Sarli L, Sansebastiano G, Jotti GS, Peracchia A. Prognostic value of ploidy, cell proliferation kinetics, and conventional clinicopathologic criteria in patients with colorectal carcinoma: a prospective study. Dis Colon Rectum 1996;39:494–503.PubMedCrossRef
69.
Zurück zum Zitat Sampedro A, Urdiales G, Martinez-Nistal A, Riera J, Hardisson D. Prognostic value of DNA image cytometry in colorectal carcinoma. Anal Quant Cytol Histol 1996;18:214-0.PubMed Sampedro A, Urdiales G, Martinez-Nistal A, Riera J, Hardisson D. Prognostic value of DNA image cytometry in colorectal carcinoma. Anal Quant Cytol Histol 1996;18:214-0.PubMed
70.
Zurück zum Zitat Diaz Aguirregoitia FJ, Garcia-Alonso Montoya I, et al. Prognostic value of nuclear DNA of 106 colorectal tumors, determined with microspectrocytophotometry [in Spanish]. Rev Esp Enferm Dig 1993;83:421-.PubMed Diaz Aguirregoitia FJ, Garcia-Alonso Montoya I, et al. Prognostic value of nuclear DNA of 106 colorectal tumors, determined with microspectrocytophotometry [in Spanish]. Rev Esp Enferm Dig 1993;83:421-.PubMed
71.
Zurück zum Zitat Tomoda H, Kakeji Y, Furusawa M. Prognostic significance of flow cytometric analysis of DNA content in colorectal cancer: a prospective study. J Surg Oncol 1993;53:144-.PubMedCrossRef Tomoda H, Kakeji Y, Furusawa M. Prognostic significance of flow cytometric analysis of DNA content in colorectal cancer: a prospective study. J Surg Oncol 1993;53:144-.PubMedCrossRef
72.
Zurück zum Zitat Tomoda H, Baba H, Saito T, Wada S. DNA index as a significant predictor of recurrence in colorectal cancer. Dis Colon Rectum 1998;41:286-0.PubMedCrossRef Tomoda H, Baba H, Saito T, Wada S. DNA index as a significant predictor of recurrence in colorectal cancer. Dis Colon Rectum 1998;41:286-0.PubMedCrossRef
73.
Zurück zum Zitat Baretton GB, Vogt M, Muller C, et al. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II). Scand J Gastroenterol 1996;31:481-.PubMedCrossRef Baretton GB, Vogt M, Muller C, et al. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II). Scand J Gastroenterol 1996;31:481-.PubMedCrossRef
74.
Zurück zum Zitat Cohn KH, Ornstein DL, Wang F, et al. The significance of allelic deletions and aneuploidy in colorectal carcinoma. Results of a 5-year follow-up study. Cancer 1997;79:233-4.PubMedCrossRef Cohn KH, Ornstein DL, Wang F, et al. The significance of allelic deletions and aneuploidy in colorectal carcinoma. Results of a 5-year follow-up study. Cancer 1997;79:233-4.PubMedCrossRef
75.
Zurück zum Zitat Kato M, Saji S, Tsuya H, et al. Clinical study of the relationship between cytological behavior and postoperative prognosis in colorectal cancer cases with special reference to nuclear DNA content and nucleolar organizer regions. J Surg Oncol 1997;64:36–41.PubMedCrossRef Kato M, Saji S, Tsuya H, et al. Clinical study of the relationship between cytological behavior and postoperative prognosis in colorectal cancer cases with special reference to nuclear DNA content and nucleolar organizer regions. J Surg Oncol 1997;64:36–41.PubMedCrossRef
76.
Zurück zum Zitat Salud A, Porcel JM, Raikundalia B, Camplejohn RS, Taub NA. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer. J Surg Oncol 1999;72:167-4.PubMedCrossRef Salud A, Porcel JM, Raikundalia B, Camplejohn RS, Taub NA. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer. J Surg Oncol 1999;72:167-4.PubMedCrossRef
77.
Zurück zum Zitat Purdie CA, Piris J. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Histopathology 2000;36:121-.PubMedCrossRef Purdie CA, Piris J. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Histopathology 2000;36:121-.PubMedCrossRef
78.
Zurück zum Zitat Chen HS, Sheen-Chen SM, Lu CC. DNA index and S-phase fraction in curative resection of colorectal adenocarcinoma: analysis of prognosis and current trends. World J Surg 2002;26:626-0.PubMedCrossRef Chen HS, Sheen-Chen SM, Lu CC. DNA index and S-phase fraction in curative resection of colorectal adenocarcinoma: analysis of prognosis and current trends. World J Surg 2002;26:626-0.PubMedCrossRef
79.
Zurück zum Zitat Rognum TO, Lund E, Meling GI, Langmark F. Near diploid large bowel carcinomas have better five-year survival than aneuploid ones. Cancer 1991;68:1077-1.PubMedCrossRef Rognum TO, Lund E, Meling GI, Langmark F. Near diploid large bowel carcinomas have better five-year survival than aneuploid ones. Cancer 1991;68:1077-1.PubMedCrossRef
80.
Zurück zum Zitat Nori D, Merimsky O, Saw D, Cortes E, Chen E, Chassin J. Tumor ploidy as a risk factor for disease recurrence and short survival in surgically treated Dukes-B2 colon cancer patients. Tumour Biol 1996;17:75–80.PubMedCrossRef Nori D, Merimsky O, Saw D, Cortes E, Chen E, Chassin J. Tumor ploidy as a risk factor for disease recurrence and short survival in surgically treated Dukes-B2 colon cancer patients. Tumour Biol 1996;17:75–80.PubMedCrossRef
81.
Zurück zum Zitat Sun XF, Carstensen JM, Stal O, Zhang H, Boeryd B, Nordenskjold B. Interrelations of clinicopathologic variables and their prognostic value in colorectal adenocarcinoma. APMIS 1996;104:35-.PubMedCrossRef Sun XF, Carstensen JM, Stal O, Zhang H, Boeryd B, Nordenskjold B. Interrelations of clinicopathologic variables and their prognostic value in colorectal adenocarcinoma. APMIS 1996;104:35-.PubMedCrossRef
82.
Zurück zum Zitat Bazan V, Migliavacca M, Zanna I, et al. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. J Cancer Res Clin Oncol 2002;128:650-.PubMedCrossRef Bazan V, Migliavacca M, Zanna I, et al. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. J Cancer Res Clin Oncol 2002;128:650-.PubMedCrossRef
83.
Zurück zum Zitat Scivetti P, Danova M, Riccardi A, Fiocca R, Dionigi P, Mazzini G. Prognostic significance of DNA content in large bowel carcinoma: a retrospective flow cytometric study. Cancer Lett 1989;46:213-.PubMedCrossRef Scivetti P, Danova M, Riccardi A, Fiocca R, Dionigi P, Mazzini G. Prognostic significance of DNA content in large bowel carcinoma: a retrospective flow cytometric study. Cancer Lett 1989;46:213-.PubMedCrossRef
84.
Zurück zum Zitat Jiang B, Liu CG, Wang MW, Zhao DH, Li Y, Ji XL. DNA content and its relationship with pathology and prognosis of colorectal carcinoma. Chin Med J (Engl) 1992;105:241-. Jiang B, Liu CG, Wang MW, Zhao DH, Li Y, Ji XL. DNA content and its relationship with pathology and prognosis of colorectal carcinoma. Chin Med J (Engl) 1992;105:241-.
85.
Zurück zum Zitat Armitage NC, Robins RA, Evans DF, Turner DR, Baldwin RW, Hardcastle JD. The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg 1985;72:828-0.PubMedCrossRef Armitage NC, Robins RA, Evans DF, Turner DR, Baldwin RW, Hardcastle JD. The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg 1985;72:828-0.PubMedCrossRef
86.
Zurück zum Zitat Kokal W, Sheibani K, Terz J, Harada JR. Tumor DNA content in the prognosis of colorectal carcinoma. JAMA 1986;255:3123-.PubMedCrossRef Kokal W, Sheibani K, Terz J, Harada JR. Tumor DNA content in the prognosis of colorectal carcinoma. JAMA 1986;255:3123-.PubMedCrossRef
87.
Zurück zum Zitat Goh HS, Jass JR, Atkin WS, Cuzick J, Northover JM. Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis. Int J Colorectal Dis 1987;2:17–21.PubMedCrossRef Goh HS, Jass JR, Atkin WS, Cuzick J, Northover JM. Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis. Int J Colorectal Dis 1987;2:17–21.PubMedCrossRef
88.
Zurück zum Zitat Scott NA, Wieand HS, Moertel CG, Cha SS, Beart RW, Lieber MM. Colorectal cancer. Dukes-stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 1987;122:1375-.PubMed Scott NA, Wieand HS, Moertel CG, Cha SS, Beart RW, Lieber MM. Colorectal cancer. Dukes-stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 1987;122:1375-.PubMed
89.
Zurück zum Zitat Tsuchiya A, Ando Y, Ishii Y, Yoshida T, Abe R. Flow cytometric DNA analysis in Japanese colorectal cancer. A multivariate analysis. Eur J Surg Oncol 1992;18:585-0.PubMed Tsuchiya A, Ando Y, Ishii Y, Yoshida T, Abe R. Flow cytometric DNA analysis in Japanese colorectal cancer. A multivariate analysis. Eur J Surg Oncol 1992;18:585-0.PubMed
90.
Zurück zum Zitat Quirke P, Dixon MF, Clayden AD, et al. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol 1987;151:285-1.PubMedCrossRef Quirke P, Dixon MF, Clayden AD, et al. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol 1987;151:285-1.PubMedCrossRef
91.
Zurück zum Zitat Fausel RE, Burleigh W, Kaminsky DB. DNA quantification in colorectal carcinoma using flow and image analysis cytometry. Anal Quant Cytol Histol 1990;12:21-.PubMed Fausel RE, Burleigh W, Kaminsky DB. DNA quantification in colorectal carcinoma using flow and image analysis cytometry. Anal Quant Cytol Histol 1990;12:21-.PubMed
92.
Zurück zum Zitat Emdin SO, Stenling R, Roos G. Prognostic value of DNA content in colorectal carcinoma. A flow cytometric study with some methodologic aspects. Cancer 1987;60:1282-.PubMedCrossRef Emdin SO, Stenling R, Roos G. Prognostic value of DNA content in colorectal carcinoma. A flow cytometric study with some methodologic aspects. Cancer 1987;60:1282-.PubMedCrossRef
93.
Zurück zum Zitat Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-.PubMed Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-.PubMed
94.
Zurück zum Zitat Crissman JD, Zarbo RJ, Ma CK, Visscher DW. Histopathologic parameters and DNA analysis in colorectal adenocarcinomas. Pathol Annu 1989;24:103-7.PubMed Crissman JD, Zarbo RJ, Ma CK, Visscher DW. Histopathologic parameters and DNA analysis in colorectal adenocarcinomas. Pathol Annu 1989;24:103-7.PubMed
95.
Zurück zum Zitat Armitage NC, Ballantyne KC, Sheffield JP, Clarke P, Evans DF, Hardcastle JD. A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer. Cancer 1991;67:2599-04.PubMedCrossRef Armitage NC, Ballantyne KC, Sheffield JP, Clarke P, Evans DF, Hardcastle JD. A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer. Cancer 1991;67:2599-04.PubMedCrossRef
96.
Zurück zum Zitat Tribukait B, Hammarberg C, Rubio C. Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes-classification and to histopathological differentiation. A flow-cytometric DNA study. Acta Pathol Microbiol Immunol Scand [A] 1983;91:89–95. Tribukait B, Hammarberg C, Rubio C. Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes-classification and to histopathological differentiation. A flow-cytometric DNA study. Acta Pathol Microbiol Immunol Scand [A] 1983;91:89–95.
97.
Zurück zum Zitat Jones DJ, Moore M, Schofield PF. Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Br J Surg 1988;75:28–33.PubMedCrossRef Jones DJ, Moore M, Schofield PF. Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Br J Surg 1988;75:28–33.PubMedCrossRef
98.
Zurück zum Zitat Kouri M, Pyrhonen S, Mecklin JP, et al. The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study. Br J Cancer 1990;62:976-1.PubMed Kouri M, Pyrhonen S, Mecklin JP, et al. The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study. Br J Cancer 1990;62:976-1.PubMed
99.
Zurück zum Zitat Hood DL, Petras RE, Edinger M, Fazio V, Tubbs RR. Deoxyribonucleic acid ploidy and cell cycle analysis of colorectal carcinoma by flow cytometry. A prospective study of 137 cases using fresh whole cell suspensions. Am J Clin Pathol 1990;93:615-0.PubMed Hood DL, Petras RE, Edinger M, Fazio V, Tubbs RR. Deoxyribonucleic acid ploidy and cell cycle analysis of colorectal carcinoma by flow cytometry. A prospective study of 137 cases using fresh whole cell suspensions. Am J Clin Pathol 1990;93:615-0.PubMed
100.
Zurück zum Zitat Tomoda H, Kakeji Y, Inoue T. Flow cytometric analysis of variations in the DNA content of superficial and deep layers in colorectal cancer. J Surg Oncol 1994;57:46-.PubMedCrossRef Tomoda H, Kakeji Y, Inoue T. Flow cytometric analysis of variations in the DNA content of superficial and deep layers in colorectal cancer. J Surg Oncol 1994;57:46-.PubMedCrossRef
101.
Zurück zum Zitat Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993;341:418-2.PubMedCrossRef Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993;341:418-2.PubMedCrossRef
102.
Zurück zum Zitat Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-4.PubMedCrossRef Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-4.PubMedCrossRef
103.
Zurück zum Zitat Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2.PubMedCrossRef Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2.PubMedCrossRef
Metadaten
Titel
DNA Ploidy Status and Prognosis in Colorectal Cancer: A Meta-Analysis of Published Data
verfasst von
Sergio E. A. Araujo, M.D.
Wanderley M. Bernardo, M.D.
Angelita Habr-Gama, M.D.
Desiderio R. Kiss, M.D.
Ivan Cecconello, M.D.
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
Diseases of the Colon & Rectum / Ausgabe 11/2007
Print ISSN: 0012-3706
Elektronische ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-007-9013-6

Weitere Artikel der Ausgabe 11/2007

Diseases of the Colon & Rectum 11/2007 Zur Ausgabe

Neu im Fachgebiet Chirurgie

Weißer Hautkrebs: Ein Update zu Diagnostik und Therapie

18.07.2024 Fortbildungswoche 2024 Kongressbericht

In der aktualisierten Version der S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ gibt es neue Empfehlungen, unter anderem zu erweiterten Optionen bei aktinischer Keratose sowie zur systemischen und chirurgischen Behandlung von Plattenepithelkarzinomen. Ein Überblick.

Vier Kriterien sprechen für ein erhöhtes Risiko nach Appendektomie

17.07.2024 Appendektomie Nachrichten

Um bei Kindern den Schweregrad einer Appendizitis und drohende Komplikationen richtig einzuschätzen, können sich Chirurginnen und Chirurgen auf die intraoperativen Kriterien des US-amerikanischen NSQIP Pediatric stützen.

Partielle Nephrektomie: Videoanalysen zur Verbesserung der chirurgischen Qualität

16.07.2024 Nephrektomie Nachrichten

Je versierter Operateurinnen und Operateure sind, desto geringer ist das Risiko für Komplikationen. Eine kleine US-Studie spricht dafür, dass das auch bei Roboter-assistierten Nephrektomien gilt – und dass sich Op.-Videos für die Beurteilung eignen.        

Thrombolyse während der PCI hilft STEMI-Patienten

08.07.2024 ST-Hebungsinfarkt Nachrichten

Patienten mit ST-Hebungsinfarkten, die während der perkutanen Koronarintervention einer intrakoronaren Thrombolyse unterzogen werden, müssen weniger ernste kardiale Komplikationen fürchten. Das Blutungsrisiko steigt dadurch offenbar nicht.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.